Search

Pages

1. • Journal article

   • 

   Translocation (Y;1)(q12;q12) in hematologic malignancies. Report on two new cases, FISH characterization, and review of the literature.

   Michaux, Lucienne[UCL] Wlodarska, Iwona[UCL] Vellosa, E R Verhoef, G. Van Orshoven, A Michaux, Jean-Louis[UCL] Scheiff, Jean-Marie[UCL] Mecucci, C. Van den Berghe, H (1996) Cancer genetics and cytogenetics — Vol. 86, no. 1, p. 35-8 (1996)
2. • Speech

   • 

   Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools

   Kenis, C.[UCL] Schuermans, H.[UCL] Van Cutsem, E.[UCL] Verhoef, G.[UCL] Vansteenkiste, J.[UCL] Vergote, Ignace[UCL] Schoffski, Patrick[UCL] Milisen, K.[UCL] Flamaing, J.[UCL] Wildiers, H.[UCL] (2009) 10th Meeting of the International-Society-of-the-Geriatric-Oncology — Berlin(Germany)
3. • Journal article

   • 

   An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2 '-deoxycytidine (decitabine) in 177 patients

   Wijermans, PW Lubbert, M Verhoef, G. Klimek, V Bosly, André[UCL] (2005) Annals of Hematology — Vol. 84, p. 9-17 (2005)
4. • Journal article

   • 

   Dasatinib (Sprycel®) use in daily clinical practice : a Belgian observational retrospective study in patients with chronic myeloid leukaemia and Philadelphia positive acute lymphatic leukaemia who are resistant or intolerant to prior therapies including imatinib

   Martiat, Ph. Bosly, André[UCL] Noens, L. Verhoef, G. Houssa, B. Lacante, P. (2012) Belgian Journal of Hematology — Vol. 3, no.2, p. 51-58 (2012)
5. • Speech

   • 

   Consistent amplification of JAK2 in hematological malignancies with hsr(9)(p).

   Wlodarska, Iwona[UCL] Michaux, Lucienne[UCL] Cools, Jan Peeters, Patrick[UCL] Franke, S. Verhoef, G. Achten, R. De Wolf-Peeters, C. Hagemeijer, Anne[UCL] Marynen, Peter[UCL] (2000) —
6. • Speech

   • 

   DNA demethylating therapy in MDS: The experience with 5-AZA-2 '-deoxycytidine (decitabine).

   Wijermans, P Ferrant, Augustin[UCL] Luebbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc Haak, H (1999) —
7. • Journal article

   • 

   Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS

   de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)
8. • Journal article

   • 

   Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.

   Bosly, André[UCL] Bron, D. Van Hoof, A. De Bock, R Berneman, Z. Ferrant, Augustin[UCL] Kaufman, L. Dauwe, M Verhoef, G. (2008) Annals of Hematology — Vol. 87, no. 4, p. 277-283 (2008)
9. • Journal article

   • 

   Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

   Vandenberghe, Peter[UCL] Michaux, Lucienne[UCL] Wlodarska, Iwona[UCL] Zachee, P. Boogaerts, M. Vanstraelen, D Herregods, MC Van Hoof, A. Selleslag, D. Roufosse, F Maerevoet, M. Verhoef, G. Cools, Jan Gilliland, DG Hagemeijer, Anne[UCL] Marynen, Peter[UCL] (2004) Leukemia — Vol. 18, no. 4, p. 734-42 (2004)
10. • Speech

    • 

    Trisomy 13 in myeloid malignancies: Clinical, morphologic and immunologic correlations and characterization by combined immunophenotyping and interphase fluorescence in situ hybridization (FISH).

    Michaux, Lucienne[UCL] Ferrant, Augustin[UCL] Dierlamm, J. Zeller, W. Deneys, Véronique[UCL] Wlodarska, Iwona[UCL] Scheiff, Jean-Marie[UCL] Criel, A. Meeus, Peter[UCL] Michaux, JL. Selleslag, D. Verhoef, G. Hernandez, JM. Dumoulin, Christine[UCL] Vandenberghe, Hans Hagemeijer, Anne[UCL] (1996) —
11. • Speech

    • 

    Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.

    Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) —
12. • Journal article

    • 

    MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23

    Michaux, Lucienne[UCL] Ferrant, Augustin[UCL] Wlodarska, Iwona[UCL] Stul, M. Dierlamm, J. Mugneret, Francine Herens, C. Beverloo, B Verhest, A. Dumoulin, Christine[UCL] Verhoef, G. Selleslag, M Madoe, V Lecomte, M. Deprijck, B. Delannoy, André[UCL] Marichal, S. Duhem, C Dicato, M. Hagemeijer, Anne[UCL] (2000) Genes, Chromosomes & Cancer — Vol. 29, no. 1, p. 40-47 (2000)
13. • Journal article

    • 

    Deletions of the long arm of chromosome 7 in myeloid disorders: Loss of band 7q32 implies worst prognosis

    Velloso, ERP Michaux, Lucienne[UCL] Ferrant, Augustin[UCL] Hernandez, JM. Meeus, Peter[UCL] Dierlamm, J. Criel, A. Louwagie, A. Verhoef, G. Boogaerts, M. Michaux, JL. Bosly, André[UCL] Mecucci, C. Vandenberghe, Hans (1996) British Journal of Haematology — Vol. 92, no. 3, p. 574-581 (1996)
14. • Journal article

    • 

    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
15. • Journal article

    • 

    Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2 '-deoxycytidine

    Lubbert, M Ferrant, Augustin[UCL] Wijermans, P Kunzmann, R Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2001) British Journal of Haematology — Vol. 114, no. 2, p. 349-357 (2001)
16. • Journal article

    • 

    Guidelines of the Belgian hamatological Society for newly diagnosed and relapsed follicular lymphoma 2012.

    Debussche , S. Van Hoof, A. Sonet, Anne[UCL] Bonnet, C. Janssens, A. Verhoef, G. Dierickx, D. De Wilde, V. Bron, D. Schroyens, W. Van Den Neste, E. Offner, F. (2012) Belgian Journal of Hematology — Vol. 3, no.2, p. 41-50 (2012)
17. • Journal article

    • 

    Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients

    Wijermans, P Ferrant, Augustin[UCL] Lubbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (2000) Journal of Clinical Oncology — Vol. 18, no. 5, p. 956-962 (2000)
18. • Journal article

    • 

    BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2012

    Janssens, A.[UCL] Van Den Neste, Eric[UCL] Schroyens, W. André, Marc[UCL] Van Hoof, A. De Wilde, V. Verhoef, G. Offner, F. Bron, D. (2012) Belgian Journal of Hematology — Vol. 3, no.4, p. 134-143 (2012)
19. • Journal article

    • 

    Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short review.

    Guillaume, Benoît[UCL] Ameye, Geneviève[UCL] Dierlamm, J. Verhoef, G. Duhem, C Ferrant, Augustin[UCL] Hagemeijer, Anne[UCL] Dumoulin, Christine[UCL] Michaux, Lucienne[UCL] (2001) Cancer genetics and cytogenetics — Vol. 128, no. 2, p. 168-71 (2001)
20. • Speech

    • 

    Amplification of chromosome 11q23 involving the MLL gene is recurrently observed in myeloid leukemias.

    Michaux, Lucienne[UCL] Dierlamm, J. Stul, M. Wlodarska, Iwona[UCL] Herens, C. Beverloo, B Duhem, C Lecomte, M. Verhoef, G. Dumoulin, Christine[UCL] Hagemeijer, Anne[UCL] (1998) —
21. • Speech

    • 

    A phase II study with low dose decitabine, a DNA hypomethylating pyrimidine analogue, in high risk MDS patients.

    Wijermans, P Ferrant, Augustin[UCL] Lubbert, M Verhoef, G. Bosly, André[UCL] Ravoet, C André, Marc (1998) —
22. • Speech

    • 

    Rituximab in Auto-immune Haemolytic Anaemia and Immune Thrombocytopenic Purpura: a Belgian Retrospective Multicentric Study

    Dierickx, D.[UCL] Vermylen, Christiane[UCL] Verhoef, G.[UCL] Van Hoof, A. Mineur, P. Roest, A. Triffet, A. Kentos, A. Pierre, Patrick[UCL] Boulet, D. Bries, G. Le, P. Q. Deprijk, B. De Samblanx, H. Drese, M. F. Kargar, K. Uyttebroeck, A.[UCL] Delforge, Michel[UCL] Janssens, A.[UCL] Keppens, C. Delannoy, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin (Germany)
23. • Speech

    • 

    Early restaging positron emmision tomography (PET) with 18F-fluorodeoxyglucose ((18)FDG) predicts outcome in patients with aggressive non Hodgkin's lymphoma (NHL).

    Spaepen, K Stroobants, Sigrid[UCL] Dupont, Patrick[Department of Nuclear Medicine, University Hospital Gasthuisberg and Catholic University of Leuven, Leuven, BELGIQUE] Vanderberghe, P Thomas, Jonathan[UCL] de Groot, T Balzarini, Jan De Wolf-Peeters, C. Mortelmans, L Verhoef, G. (2001) —
24. • Journal article

    • 

    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)

    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
25. • Speech

    • 

    Rituximab therapy for immune anemia and thrombocytopenia: A Belgian registry run by the red cell subcomittee of the belgian society for hematology

    Dierickx, D. Vermylen, Christiane[UCL] Triffet, A. Mineur, P. Kentos, A. Ferster, A. Boulet, D. Deprijk, B. Beguin, Y. Dresse, M. E. Kargar, K. Verhoef, G. Delannoy, André[UCL] (2007) 12th Congress of the European-Hematology-Association — Vienna (Austria)

Pages